Literature DB >> 19798073

The effect of mannan oligosaccharide supplementation on body weight gain and fat accrual in C57Bl/6J mice.

Daniel L Smith1, Tim R Nagy, Landon S Wilson, Shengli Dong, Stephen Barnes, David B Allison.   

Abstract

The prevalence of obesity in industrialized societies has become markedly elevated. In contrast, model organism research shows that reducing caloric intake below ad libitum levels provides many health and longevity benefits. Despite these benefits, few people are willing and able to reduce caloric intake over prolonged periods. Prior research suggests that mannooligosaccharide (MOS or mannan) supplementation can increase lifespan of some livestock and in rodents can reduce visceral fat without reducing caloric intake. Hence, we tested the effect of MOS supplementation as a possible calorie restriction (CR) mimetic (CRM) in mice. C57Bl/6J male mice were fed a high-fat "western" type diet with or without 1% MOS (by weight) supplementation (n = 24/group) from 8 to 20 weeks of age. Animals were housed individually and provided 95% of ad libitum food intake throughout the study. Body weight was measured weekly and body composition (lean and fat mass) measured noninvasively every 3 weeks. Individual fat depot weights were acquired by dissection at study completion. Supplementation of a high-fat diet with 1% MOS tended to reduce total food intake (mean +/- s.d.; control (CON): 293.69 +/- 10.53 g, MOS: 288.10 +/- 11.82 g; P = 0.09) during the study. Moreover, MOS supplementation had no significant effect on final body weight (CON: 25.21 +/- 2.31 g, MOS: 25.28 +/- 1.49 g; P = 0.91), total fat (CON: 4.72 +/- 0.90 g, MOS: 4.82 +/- 0.83 g; P = 0.69), or visceral fat (CON: 1.048 +/- 0.276 g, MOS: 1.004 +/- 0.247 g; P = 0.57). Contrary to previous research, MOS supplementation had no discernable effect on body weight gain or composition during this 12-week study, challenging the potential use of MOS as a CRM or body composition enhancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19798073      PMCID: PMC2940117          DOI: 10.1038/oby.2009.308

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  21 in total

Review 1.  Controlling caloric consumption: protocols for rodents and rhesus monkeys.

Authors:  T D Pugh; R G Klopp; R Weindruch
Journal:  Neurobiol Aging       Date:  1999 Mar-Apr       Impact factor: 4.673

2.  The effect of retarded growth upon the length of life span and upon the ultimate body size. 1935.

Authors:  C M McCay; M F Crowell; L A Maynard
Journal:  Nutrition       Date:  1989 May-Jun       Impact factor: 4.008

Review 3.  Inulin, oligofructose and bone health: experimental approaches and mechanisms.

Authors:  Connie M Weaver
Journal:  Br J Nutr       Date:  2005-04       Impact factor: 3.718

Review 4.  Glucomannan and obesity: a critical review.

Authors:  Joyce Keithley; Barbara Swanson
Journal:  Altern Ther Health Med       Date:  2005 Nov-Dec       Impact factor: 1.305

Review 5.  Obesity: adverse effects on health and longevity.

Authors:  T B Van Itallie
Journal:  Am J Clin Nutr       Date:  1979-12       Impact factor: 7.045

Review 6.  Konjac-Mannan and American ginsing: emerging alternative therapies for type 2 diabetes mellitus.

Authors:  V Vuksan; J L Sievenpiper; Z Xu; E Y Wong; A L Jenkins; U Beljan-Zdravkovic; L A Leiter; R G Josse; M P Stavro
Journal:  J Am Coll Nutr       Date:  2001-10       Impact factor: 3.169

Review 7.  An overview of mannan structure and mannan-degrading enzyme systems.

Authors:  L R S Moreira; E X F Filho
Journal:  Appl Microbiol Biotechnol       Date:  2008-05       Impact factor: 4.813

Review 8.  Development of calorie restriction mimetics as a prolongevity strategy.

Authors:  Donald K Ingram; R Michael Anson; Rafael de Cabo; Jacek Mamczarz; Min Zhu; Julie Mattison; Mark A Lane; George S Roth
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

9.  Years of life lost due to obesity.

Authors:  Kevin R Fontaine; David T Redden; Chenxi Wang; Andrew O Westfall; David B Allison
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake.

Authors:  R Weindruch; R L Walford; S Fligiel; D Guthrie
Journal:  J Nutr       Date:  1986-04       Impact factor: 4.798

View more
  4 in total

1.  Efficient recombinant expression and secretion of a thermostable GH26 mannan endo-1,4-beta-mannosidase from Bacillus licheniformis in Escherichia coli.

Authors:  Chomphunuch Songsiriritthigul; Bancha Buranabanyat; Dietmar Haltrich; Montarop Yamabhai
Journal:  Microb Cell Fact       Date:  2010-04-11       Impact factor: 5.328

2.  Cloning, secretory expression and characterization of recombinant β-mannanase from Bacillus circulans NT 6.7.

Authors:  Yotthachai Piwpankaew; Supa Sakulsirirat; Sunee Nitisinprasert; Thu-Ha Nguyen; Dietmar Haltrich; Suttipun Keawsompong
Journal:  Springerplus       Date:  2014-08-13

3.  Cloning and biochemical characterization of an endo-1,4-β-mannanase from the coffee berry borer Hypothenemus hampei.

Authors:  Carolina Aguilera-Gálvez; Juan J Vásquez-Ospina; Pablo Gutiérrez-Sanchez; Ricardo Acuña-Zornosa
Journal:  BMC Res Notes       Date:  2013-08-22

4.  Dietary yeast-derived mannan oligosaccharides have immune-modulatory properties but do not improve high fat diet-induced obesity and glucose intolerance.

Authors:  Lisa R Hoving; Hendrik J P van der Zande; Amanda Pronk; Bruno Guigas; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  PLoS One       Date:  2018-05-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.